Sank Leonard 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Aug 10, 2022
Insider Transaction Report
Form 4
Sank Leonard
Director
Transactions
- Tax Payment
Common Stock
2022-08-08$8.77/sh−9,304$81,596→ 28,696 total - Exercise/Conversion
Common Stock
2022-08-08$4.08/sh+20,000$81,600→ 38,000 total - Exercise/Conversion
Stock Option
2022-08-08−20,000→ 0 totalExercise: $4.08Exp: 2022-08-08→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents a cashless exercise of outstanding stock options to purchase 20,000 shares of common stock. The reporting person received 10,696 shares of common stock and surrendered 9,304 shares of common stock underlying the stock option in payment of the exercise price.
- [F2]The options vested as follows: 10,000 vested on each of January 1, 2013 and 2014.